# Bolt Biotherapeutics, Inc.: Form 8-K, filed May 14, 2024

- Company: [Bolt Biotherapeutics, Inc.](/companies/bolt.md) (CIK 1641281)
- Form: 8-K
- Filed: 2024-05-14
- Accepted by EDGAR: May 14, 2024, 16:06 ET
- Period: 2024-05-13
- Accession: 0000950170-24-059524
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1641281/000095017024059524/bolt-20240513.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1641281/000095017024059524/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1641281/000095017024059524/bolt-20240513.htm

Filed May 14, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-059524. Last ingested by Listed: Oct 27, 2026, 17:22 ET. No prices; not investment advice.